AFFINIA THERAPEUTICS
Affinia Therapeutics is a developer of a platform for rationally designed adeno-associated virus (AAV) vectors and gene therapies intended to develop medicines for devastating diseases. The company leverages synthetic and systems biology combined with high-throughput screening and tissue and single-cell resolution for people affected by muscle and central nervous system (CNS) diseases with significant unmet needs, thereby providing medical professionals with the rational design of novel vectors and gene therapies with remarkably improved properties.
AFFINIA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2019-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.affiniatx.com
Total Employee:
51+
Status:
Active
Contact:
617-430-7817
Email Addresses:
[email protected]
Total Funding:
170 M USD
Technology used in webpage:
Google Maps U.S. Server Location Google Maps API Microsoft Microsoft Azure Google Maps For Work Microsoft Azure US East Region
Similar Organizations
Areteia Therapeutics
Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.
Artiva Biotherapeutics
Artiva Biotherapeutics is a biotech company focused on developing and commercializing allogeneic natural killer (NK) cell therapies.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Design Therapeutics
Design Therapeutics is a biotechnology company developing a new class of therapies for serious degenerative disorders.
Freeline
Freeline Therapeutics is a biotechnology company focused on developing liver directed gene therapies for a range of diseases.
Mythic Therapeutics
Mythic Therapeutics is a biotechnology company focused on a new generation of groundbreaking cancer therapeutics.
Prevail Therapeutics
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Rallybio
Rallybio is an biotechnological research and development services intended to transform the lives of patients with a devastating disease.
SalioGen Therapeutics
SalioGen Therapeutics is a gene coding company that develops potentially curative therapies for patients with inherited disorders.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Woodline Partners
Woodline Partners investment in Series B - Affinia Therapeutics
TCG Crossover
TCG Crossover investment in Series B - Affinia Therapeutics
Octagon Capital Advisors
Octagon Capital Advisors investment in Series B - Affinia Therapeutics
Atlas Venture
Atlas Venture investment in Series B - Affinia Therapeutics
Farallon Capital Management
Farallon Capital Management investment in Series B - Affinia Therapeutics
Casdin Capital
Casdin Capital investment in Series B - Affinia Therapeutics
Perceptive Advisors
Perceptive Advisors investment in Series B - Affinia Therapeutics
Lonza
Lonza investment in Series B - Affinia Therapeutics
Google Ventures
Google Ventures investment in Series B - Affinia Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Affinia Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-14 | Affinia Therapeutics Appoints Thomas Leggett as Chief Financial Officer |
Official Site Inspections
http://www.affiniatx.com Semrush global rank: 4.97 M Semrush visits lastest month: 1.69 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Affinia Therapeutics"
Affinia Therapeutics - Crunchbase Company Profile
Organization. Affinia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 617-430-7817; Affinia Therapeutics …See details»
Affinia Therapeutics - LinkedIn
Congrats to our AffiniaTx ESGCT24 team for a successful congress ... Her organization represents what is commonly known as "the most innovative square mile on the planet" - more biotechs than ...See details»
Affinia Therapeutics Company Profile 2024: Valuation, …
Information on valuation, funding, cap tables, investors, and executives for Affinia Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Affinia Therapeutics - Overview, News & Similar companies
Jun 26, 2024 Affinia Therapeutics contact info: Phone number: (617) 430-7817 Website: www.affiniatx.com What does Affinia Therapeutics do? Founded in 2019, Affinia Therapeutics …See details»
Affinia Therapeutics and Forge Biologics Announce AAV cGMP ...
Nov 13, 2024 For more information, visit https://www.affiniatx.com. About Forge Biologics. Forge Biologics, a member of Ajinomoto Bio-Pharma Services, is a hybrid gene therapy contract …See details»
Affinia Therapeutics Strengthens Leadership Team with …
WALTHAM, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally-designed adeno-associated …See details»
Affinia Therapeutics Strengthens Leadership Team with
WALTHAM, Mass., March 08, 2022 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for...See details»
Corporate Presentation - Affini-T Therapeutics
© August 2023 | Non-Confidential 8 G12C Cysteine (C) G12D Aspartic acid (D) G12V Valine (V) G12R Arginine (R) G12Q Glutamine139K (Q) Other Kirsten Rat SarcomaSee details»
Affinia Therapeutics Announces Addition of Gene Therapy …
Feb 17, 2021 -- Gene editing expert Charles Albright, Ph.D., joins as chief scientific officer -- -- Gene therapy development expert Petra Kaufmann, M.D., joins as chief medical officer – …See details»
Affinia Therapeutics Appoints Thomas Leggett as Chief Financial …
WALTHAM, Mass., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally-designed adeno-associated …See details»
Affinia Therapeutics Announces Addition of Gene Therapy
Feb 17, 2021 -- Gene editing expert Charles Albright, Ph.D., joins as chief scientific officer -- -- Gene therapy development expert Petra Kaufmann, M.D., joins as...See details»
Affini-T Therapeutics | Unlocking the power of T cells
11.06.2024. Affini-T Therapeutics to Present Trial-in-Progress Poster and Preclinical Data from Its Oncogenic Driver Programs Targeting TP53 R175H, KRAS G12D and KRAS-G12V at the …See details»
Affinia Therapeutics Raises $60M in Series A Financing to
Mar 31, 2020 Lead Venture Investors Include Atlas Venture, F-Prime Capital and NEA; Industry Veterans Sean Nolan and Rick Modi Join Forces with Renowned Scientific Co-founders Luk …See details»
Vertex Pharmaceuticals and Affinia Therapeutics Establish Multi …
Apr 27, 2020 www.affiniatx.com. About Vertex Pharmaceuticals Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with …See details»
Affinia Therapeutics to Participate in the 2024 Jefferies Global ...
May 28, 2024 Affinia Therapeutics ("Affinia"), an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated virus (AAV) vectors and gene …See details»
Affinia Therapeutics to Present New Data and Updates on AAV …
WALTHAM, Mass., April 27, 2021 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated …See details»
Affinia Therapeutics Announces Indications for Lead Gene
Sep 8, 2021 Indications include metachromatic leukodystrophy, a rare, progressive, and fatal disease affecting the nervous system, and brain metastases secondary to HER2+ breast …See details»
Affinia Therapeutics Announces Collaboration with the Institute of ...
Jul 20, 2021 – Botond Roska, M.D., Ph.D., world-renowned scientist and Director at IOB and scientific co-founder of Affinia Therapeutics, will oversee collaboration – – Collaboration will …See details»
Affinia Therapeutics Presents New Data and Updates on AAV
WALTHAM, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Affinia Therapeutics, an innovative gene therapy company with a proprietary platform for rationally designed adeno-associated …See details»
Affinia Therapeutics Presents New Data and Updates on AAV …
May 13, 2021 Data shows multiple vectors with superiority to AAV9 in CNS, systemic approaches to target muscle while detargeting liver, and improvements in …See details»